11b,17a,21-Trihydroxypreg-nenolone

Metabolite details

Identifier

HAFVWTUQBYRPOB-QGGNSXJXSA-N

InChI Key

HAFVWTUQBYRPOB-QGGNSXJXSA-N

IUPAC name

2-hydroxy-1-[(17R)-3,11,17-trihydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]ethanone

Preferred name

11b,17a,21-Trihydroxypreg-nenolone

INN name

—

Synonym

—

ChEBI

CHEBI:171954

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_nsPEF_7_day
• Control_vs_Lithogenic_Diet
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d